BrainJuicer reports 14% rise in first-half sales as Popper departs
The company published interim results today for the six months ending 30 June showing revenue figures of £10.3m, up from £9m in the same period last year. Operating profit was also up 14% for the same period from £628k to £716k.
The UK business represents 37% of revenues and the US 33%. BrainJuicer says that UK figures are 3% up on last year, while the US is 16% higher.
Overseas ventures in Switzerland, China and Brazil performed well, the company said, but Germany and the Netherlands showed signs of weakness resulting in a restructure combining the two countries’ operations under the management of the firm’s Germany boss.
John Kearon, founder of BrainJuicer (pictured with CFO James Geddes), said: “We continue to gain traction with the major buyers of market research in the large and statistically important markets in which our clients operate.”
BrainJuicer recently opened a new practice in India and hired former McKinsey partner Pooja Haldea as managing director for the country.
- In other news today, Ari Popper, BrainJuicer’s US head, has announced he is to leave the company to set up his own innovation consultancy SciFutures. The agency will use science fiction narratives and nonlinear thinking to help inspire businesses. Three of his senior team – EVPs Alex Hunt, Brent Snider and Rene Huey-Lipton – will now jointly run the US operation looking after the Midwest and West Coast, East Coast and Southern US, and the qualitative Juice Generation services respectively.

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments